Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

Cited by (1,007)

Items 501–600 of 1,007

1. Relationship Between Vein Graft Failure and Subsequent Clinical Outcomes After Coronary Artery Bypass Surgery
   Renato D. Lópes, Rajendra H. Mehta, Gail E. Hafley, Judson B. Williams, Michael J. Mack, Eric David Peterson, Keith B. Allen, Robert A. Harrington, Charles Michael Gibson, Robert M. Califf et al. · 2012 · Circulation
2. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
   Robert F. Storey, Stefan Karl James, Agneta G Siegbahn, Christoph Varenhorst, Claes Held, Joseph W. Yčas, Steen Husted, Christopher Paul Cannon, Richard Clinton Becker, Philippe Gabríel Steg et al. · 2013 · Platelets
3. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
   Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Andrzej Budaj, Rosa Coppolecchia, John W. Eikelboom, Stefan Karl James, W. Schuyler Jones, Béla Péter Merkely, Lars Keller et al. · 2022 · Circulation
4. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures
   Marc J. Zuckerman, William K. Hirota, Douglas G. Adler, Raquel E. Davila, Brian C. Jacobson, Jonathan A. Leighton, Waqar Qureshi, Elizabeth Rajan, Ralph David Hambrick, Robert D. Fanelli et al. · 2005 · Gastrointestinal Endoscopy
5. Platelet Glycoprotein IIb/IIIa Inhibitors
   Martin J. Quinn, Edward F. Plow, Eric J. Topol · 2002 · Circulation
6. Narrative Review: Aspirin Resistance and Its Clinical Implications
   Simon Sanderson, Jon David Emery, Trevor P Baglin, Ann‐Louise Kinmonth · 2005 · Annals of Internal Medicine
7. Sex differences in mechanisms, presentation and management of ischaemic heart disease
   Filippo Crea, Irma Battipaglia, Felicita Andreotti · 2015 · Atherosclerosis
8. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction
   Christopher Labos, Kaberi Dasgupta, Hacene Nedjar, Gustavo Turecki, Elham Rahme · 2011 · Canadian Medical Association Journal
9. Cardiovascular Disease in Type 2 Diabetes Mellitus
   Arshag D. Mooradian · 2003 · Archives of Internal Medicine
10. Clopidogrel Withdrawal Is Associated With Proinflammatory and Prothrombotic Effects in Patients With Diabetes and Coronary Artery Disease
    Dominick Joseph Angiolillo, Antonio Fernández‐Ortíz, Esther Bernardo, Celia Ramírez, Manel Sabaté, Pilar Jiménez‐Quevedo, Rosana Hernández, Raúl Moreno, Javier Escaned, Fernándo Alfonso et al. · 2006 · Diabetes
11. Aspirin for Primary Prevention of Coronary Events
    Michael S. Lauer · 2002 · New England Journal of Medicine
12. Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks
    Alaa Rostom, Paul Moayyedi, Richard H. Hunt · 2008 · Alimentary Pharmacology & Therapeutics
13. Absence of Interaction Between Atorvastatin or Other Statins and Clopidogrel
    Victor L. Serebruany, Mark G. Midei, Alex I. Malinin, Benjamin R. Oshrine, David R. Lowry, David C. Sane, Jean‐François Tanguay, Steven R. Steinhubl, Peter B. Berger, Christopher M. O’Connor et al. · 2004 · Archives of Internal Medicine
14. Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
    Renli Teng · 2015 · Clinical Pharmacokinetics
15. Combining Antiplatelet and Anticoagulant Therapies
    David R. Holmes, Dean J. Kereiakes, Neal S. Kleiman, David J. Moliterno, Giuseppe Patti, Cindy Lee Grines · 2009 · Journal of the American College of Cardiology
16. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study
    Alexander Hirsch, Fons Windhausen, Jan G.P. Tijssen, Freek W.A. Verheugt, Jan Hein Cornel, Robbert J. de Winter · 2007 · The Lancet
17. Atherosclerotic Plaque Rupture
    Esther Lutgens, Robert Jan van Suylen, Birgit Faber, Marion J. Gijbels, Petra M.H. Eurlings, Ann Pascale Bijnens, Kitty B.J.M. Cleutjens, Sylvia Heeneman, Mat J.A.P. Daemen · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
18. Periodontal therapy and cardiovascular risk
    Orlandi, Marco, Graziani, Filippo, D'Aiuto, Francesco · 2020 · Periodontology 2000
19. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
    Yaling Han, Yi Li, Shouli Wang, Quanmin Jing, Zhulu Wang, Dongmei Wang, Qingfen Shu, Xiuying Tang · 2009 · American Heart Journal
20. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease
    Dominick Joseph Angiolillo, Antonio Fernández‐Ortíz, Esther Bernardo, Celia Ramírez, Ugo Cavallari, Elisabetta Trabetti, Manel Sabaté, Pilar Jiménez‐Quevedo, Rosana Hernández, Raúl Moreno et al. · 2005 · Thrombosis Research
21. Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders
    Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Jean-Philippe Mouret, Laurent Bali, Pierre-Julien Moro, Marc Lambert, Marie‐Christine Alessi, Jean‐Louis Bonnet · 2008 · JACC: Cardiovascular Interventions
22. Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy
    Shamir R. Mehta, Jean‐Pierre Bassand, Susan Chrolavicius, Rafael Díaz, Keith A.A. Fox, Christopher Bull Granger, Sanjit S. Jolly, Hans‐Jürgen Rupprecht, Petr Widimský, Salim Yusuf · 2008 · American Heart Journal
23. The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes
    John F. Martin, Steen Dalby Kristensen, Anthony Mathur, Erik Lerkevang Grove, Fizzah Choudry · 2012 · Nature Reviews Cardiology
24. Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis
    Ángel Lanas, Ping Wu, Jennie Medin, Edward J. Mills · 2011 · Clinical Gastroenterology and Hepatology
25. Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
    Michelle L. O’Donoghue, Deepak L. Bhatt, Stephen D. Wiviott, Shaun G. Goodman, Desmond J. Fitzgerald, Dominick Joseph Angiolillo, Shinya Goto, Gilles Montalescot, Uwe Zeymer, Philip E. Aylward et al. · 2011 · Circulation
26. New anticoagulants
    Jack Hirsh, Martin James O'Donnell, Jeffrey Ian Weitz · 2004 · Blood
27. The Secondary Prevention of Small Subcortical Strokes (SPS3) Study
    Oscar Benavente, Carole L. White, Lesly A. Pearce, Pablo E. Pérgola, Ana Roldan, Marie-France Benavente, Christopher S. Coffey, Leslie Ain McClure, Jeff M. Szychowski, ROBIN A. CONWIT et al. · 2011 · International Journal of Stroke
28. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014
    Karolina Elisabeth Szummer, Lars C. Wallentin, Lars Lindhagen, Joakim Alfredsson, David Erlinge, Claes Held, Stefan Karl James, Thomas Kellerth, Bertil Lindahl, Annica Ravn‐Fischer et al. · 2018 · European Heart Journal
29. Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
    Ramin Ebrahimi, Cornelius Dyke, Roxana Mehran, Steven V. Manoukian, Frederick Feit, David Alan Cox, Bernard John Gersh, E. Magnus Ohman, Harvey Douglas White, Jeffrey W. Moses et al. · 2009 · Journal of the American College of Cardiology
30. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes
    Waltraud C. Schrottmaier, Julia Barbara Kral-Pointner, Sigrun Badrnya, Alice Assinger · 2015 · Thrombosis and Haemostasis
31. New Anticoagulant Drugs
    Jeffrey Ian Weitz, Jack Hirsh, Meyer Michel Samama · 2004 · CHEST Journal
32. The difference between clopidogrel responsiveness and posttreatment platelet reactivity
    Waiel M. Samara, Kevin P. Bliden, Udaya S. Tantry, Paul Alfred Gurbel · 2004 · Thrombosis Research
33. Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
    Shinya Goto, Hisashi Ogawa, M. Takeuchi, Marcus D Flather, Deepak L. Bhatt, on behalf of the J-LANCELOT (Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin) Investigators · 2010 · European Heart Journal
34. Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties
    Nicola Ferri, Alberto Corsini, Stefano Bellosta · 2013 · Drugs
35. Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
    Robert A. Harrington, Richard Clinton Becker, Christopher Paul Cannon, David D. Gutterman, Abraham Michael Lincoff, Jeffrey J. Popma, Philippe Gabríel Steg, Gordon Henry Guyatt, Shaun G. Goodman · 2008 · CHEST Journal
36. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome
    Georgios Sidéris, Remy Cohen, Catherine Meuleman, Claire Bal dit Sollier, Olivier Barthélémy, Patrick Henry, Pascal Lim, Farzin Beygui, Jean‐Philippe Collet, Debra A. Marshall et al. · 2009 · Thrombosis and Haemostasis
37. Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
    Dominick Joseph Angiolillo · 2009 · Diabetes Care
38. Outcomes After Acute Myocardial Infarction in HIV-Infected Patients
    Luc Lorgis, Jonathan Cottenet, G. Molins, Éric Benzenine, Marianne Zeller, Hervé Aube, Claude Touzery, Joëlle Hamblin, Aurélie Gudjoncik, Yves Cottin et al. · 2013 · Circulation
39. The Relative Efficacy and Safety of Clopidogrel in Women and Men
    Jeffrey S. Berger, Deepak L. Bhatt, Christopher Paul Cannon, Zhengming Chen, Lixin Jiang, James B. Jones, Shamir R. Mehta, Marc Steven Sabatine, Steven R. Steinhubl, Eric J. Topol et al. · 2009 · Journal of the American College of Cardiology
40. The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention
    Michelle L. O’Donoghue, Sabina A. Murphy, Marc Steven Sabatine · 2020 · Circulation
41. Atorvastatin Does Not Affect the Antiplatelet Potency of Clopidogrel When It Is Administered Concomitantly for 5 Weeks in Patients With Acute Coronary Syndromes
    John V. Mitsios, Athanasios I. Papathanasiou, Foteini I. Rodis, Moses Elisaf, John A. Goudevenos, Alexandros D. Tselepis · 2004 · Circulation
42. Stabilisation of atherosclerotic plaques
    Jacob Fog Bentzon, Mat J.A.P. Daemen, Erling Falk, Hector Garcia-Garcia, Joerg Herrmann, Imo E. Hoefer, J. Wouter Jukema, Rob Krams, Brenda Renata Kwak, Nikolaus Marx et al. · 2011 · Thrombosis and Haemostasis
43. Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?
    Loren Laine, Charles H. Hennekens · 2009 · The American Journal of Gastroenterology
44. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies
    Roberta Rossini, Giuseppe Musumeci, Luigi Oltrona Visconti, Ezio Bramucci, Battistina Castiglioni, Stefano De Servi, Corrado Lettieri, Maddalena Lettino, Emanuela Piccaluga, Stefano Savonitto et al. · 2014 · EuroIntervention
45. Practical Implementation of the Guidelines for Unstable Angina/Non–ST-Segment Elevation Myocardial Infarction in the Emergency Department
    W. Brian Gibler, Christopher Paul Cannon, Andra L. Blomkalns, Douglas Mark Char, Barbara J. Drew, Judd E. Hollander, Allan S. Jaffe, Robert L. Jesse, Laura Kristin Newby, E. Magnus Ohman et al. · 2005 · Circulation
46. Dual Antiplatelet Therapy Monitoring for Neurointerventional Procedures Using a Point-of-Care Platelet Function Test: A Single-Center Experience
    Deok Hee Lee, Anıl Arat, Hesham Morsi, Hashem M. Shaltoni, Justin R. Harris, M E Mawad · 2008 · American Journal of Neuroradiology
47. Antithrombotic Therapy in the Elderly
    Davide Capodanno, Dominick Joseph Angiolillo · 2010 · Journal of the American College of Cardiology
48. Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
    Iris de Weerdt, Suzanne M. Koopmans, Arnon Philip Kater, Michel van Gelder · 2017 · Haematologica
49. Clopidogrel Responsiveness Regardless of the Discontinuation Date Predicts Increased Blood Loss and Transfusion Requirement After Off-Pump Coronary Artery Bypass Graft Surgery
    Young Lan Kwak, Jongchan Kim, Yong Seon Choi, Kyung‐Jong Yoo, Young Rim Song, Jae‐Kwang Shim · 2010 · Journal of the American College of Cardiology
50. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
    Alessandro Squizzato, Marta Bellesini, Andrea Takeda, Saskia Middeldorp, Marco Paolo Donadini · 2017 · Cochrane Database of Systematic Reviews
51. Genetics of Ischemic Stroke, Stroke-Related Risk Factors, Stroke Precursors and Treatments
    David Della‐Morte, Fiorella Guadagni, Raffaele Palmirotta, Gianluca Testa, Valeria Caso, Maurizio Paciaroni, Pasquale Abete, F. Rengo, Patrizia Ferroni, Ralph L. Sacco et al. · 2012 · Pharmacogenomics
52. Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet Therapy
    Sebastian Harder, Ute Klinkhardt, John M. Alvarez · 2004 · Clinical Pharmacokinetics
53. A dose-finding study of fondaparinux in patients with non–ST-segment elevation acute coronary syndromes
    Maarten L. Simoons, Inge W.G. Bobbink, Jean Boland, Martin Gardien, Peter Klootwijk, Anthonie W.A. Lensing, Witold Rużyłło, Victor A.W.M. Umans, Alec S. Vahanian, Frans Van de Werf et al. · 2004 · Journal of the American College of Cardiology
54. Potential therapeutic targets in the rapidly expanding field of purinergic signalling
    Geoffrey Burnstock · 2002 · Clinical Medicine
55. Efficacy and Safety of Combination Antiplatelet Therapies in Patients With Symptomatic Intracranial Atherosclerotic Stenosis
    Sun Uck Kwon, Keun‐Sik Hong, Dong‐Wha Kang, Jong‐Moo Park, Ju-Hun Lee, Yong‐Jin Cho, Kyung‐Ho Yu, Ja-Seong Koo, Ka Sing Wong, Seung‐Hoon Lee et al. · 2011 · Stroke
56. An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction
    John J. Mahmarian, Habib Abbas Dakik, Neil G. Filipchuk, Leslee J. Shaw, Sherif Iskander, Terrence David Ruddy, Felix Y. J. Keng, Milena J. Henzlova, Adel H. Allam, Lemuel A. Moyé et al. · 2006 · Journal of the American College of Cardiology
57. Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical Significance
    Scott McKee, David C. Sane, Efthymios Deliargyris · 2002 · Thrombosis and Haemostasis
58. Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents
    Jan‐Peter van Kuijk, Willem‐Jan Flu, Olaf Schouten, Sanne Elisabeth Hoeks, Lisanne Schenkeveld, Peter P.T. de Jaegere, Jeroen Joost Bax, Ron T. van Domburg, Patrick W.J.C. Serruys, Don Poldermans · 2009 · The American Journal of Cardiology
59. The influence of risk status on guideline adherence for patients with non–ST-segment elevation acute coronary syndromes
    Matthew T. Roe, Eric David Peterson, Laura Kristin Newby, Anita Y. Chen, Charles V. Pollack, Ralph G. Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, Robert M. Califf et al. · 2006 · American Heart Journal
60. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: A meta‐analysis comparing successful versus failed percutaneous intervention for chronic total occlusion
    Muhammad Fahad Khan, Christopher S. Wendel, Hoang M. Thai, Mohammad Reza Movahed · 2013 · Catheterization and Cardiovascular Interventions
61. Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children
    Jennifer S. Li, Eric S Yow, Katherine Berezny, Paula M. Bokesch, Matsato Takahashi, T.P. Graham, Stephen Pruett Sanders, Daniel Sidi, Damien Bonnet, Peter Ewert et al. · 2008 · Circulation
62. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication
    Andrew J. Feiring, Amy A. Wesolowski, Susan Lade · 2004 · Journal of the American College of Cardiology
63. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes
    Giuseppe Biondi‐Zoccai, Marzia Lotrionte, Pierfrancesco Agostoni, Antonio Abbate, Enrico Romagnoli, Giuseppe Sangiorgi, Dominick Joseph Angiolillo, Marco Valgimigli, Luca Testa, Fiorenzo Gaita et al. · 2010 · International Journal of Cardiology
64. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease
    Robert F. Storey, Robert G. Wilcox, Stan Heptinstall · 2002 · Platelets
65. Onset and Offset of Platelet Inhibition After High-Dose Clopidogrel Loading and Standard Daily Therapy Measured by a Point-of-Care Assay in Healthy Volunteers
    Matthew J. Price, Jacqueline L. Coleman, Steven R. Steinhubl, Garrett Bradley Wong, Christopher Paul Cannon, Paul S. Teirstein · 2006 · The American Journal of Cardiology
66. Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention
    Matthew J. Price, Sarah Shaw Murray, Dominick Joseph Angiolillo, Elizabeth O. Lillie, Erin N. Smith, Rebecca L. Tisch, Nicholas J. Schork, Paul S. Teirstein, Eric J. Topol · 2012 · Journal of the American College of Cardiology
67. P2Y12 platelet inhibition in clinical practice
    Peter Damman, Pier Woudstra, Wichert J. Kuijt, Robbert J. de Winter, Stefan Karl James · 2011 · Journal of Thrombosis and Thrombolysis
68. 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines
    Oksana M. Drapkina, Концевая Анна Васильевна, А. М. Калинина, S.M. Avdeev, Агальцов Михаил Викторович, L. M. Alexandrova, А. А. Анциферова, Aronov Dm, Н. М. Ахмеджанов, Yu. А. Balanova et al. · 2022 · CARDIOVASCULAR THERAPY AND PREVENTION
69. Coronary heart disease: the female heart is vulnerable
    NANETTE KASS WENGER · 2003 · Progress in Cardiovascular Diseases
70. Variability in Responsiveness to Oral Antiplatelet Therapy
    Dominick Joseph Angiolillo · 2009 · The American Journal of Cardiology
71. Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine
    Julie A. Johnson, Larisa H. Cavallari · 2013 · Pharmacological Reviews
72. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis
    Pierre A Monney, Neha Sekhri, Thomas Burchell, Charles J. Knight, Ceri Davies, Andrew Deaner, Michael Sheaff, Suhail I. Baithun, Steffen Erhard Petersen, Andrew Wragg et al. · 2010 · Heart
73. Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
    Deepak L. Bhatt, Charles V. Pollack, Jeffrey Ian Weitz, Lisa K. Jennings, Sherry Xu, Susan E. Arnold, Bret R. Umstead, Michael C. Mays, John S. Lee · 2019 · New England Journal of Medicine
74. 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
    Marco Roffi, Carlo Patrono, Jean‐Philippe Collet, Christian Eugen Mueller, Marco Valgimigli, Felicita Andreotti, Jeroen Joost Bax, Michael Andrew Borger, Carlos Brotons, Derek P. Chew et al. · 2015 · Revista Española de Cardiología (English Edition)
75. Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction
    Jordi A. Matías‐Guiu, José Manuel Ferro, José Álvarez‐Sabín, Ferràn Torres, MD Jimenez, Aida Pilar Lago, Teresa Pinho e Melo · 2003 · Stroke
76. Need to Test the Arterial Inflammation Hypothesis
    Deepak L. Bhatt, Eric J. Topol · 2002 · Circulation
77. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology*
    Michel E. Bertrand, Maarten L. Simoons, Keith A.A. Fox, Lars C. Wallentin, Christian W. Hamm, Eugene Patrick McFadden, Pim J. de Feyter, Giuśeppe Specchia, Witold Rużyłło · 2002
78. 2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
    О. Л. Барбараш, Dmitry Viktorovich Duplyakov, D. A. Zateischikov, Е. П. Панченко, Roman M. Shakhnovich, I. S. Yavelov, Aleksey N. Yakovlev, Abugov Sa, Bagrat G. Alekyan, Архипов Михаил Викторович et al. · 2021 · Russian Journal of Cardiology
79. Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations
    Jack Hirsh, Deepak L. Bhatt · 2004 · Archives of Internal Medicine
80. High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study.
    J. Silvain, G. Cayla, J. Hulot, J. Finzi, M. Kerneis, S. O'Connor, A. Bellemain-Appaix, O. Barthélémy, F. Beygui, J. Collet et al. · 2012 · European Heart Journal
81. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade
    Kirsten E. Fleischmann, Joshua A. Beckman, Christopher E.H. Buller, Hugh G Calkins, Lee A. Fleisher, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, John F. Robb et al. · 2009 · Journal of the American College of Cardiology
82. Oral Antiplatelet Therapy After Acute Coronary Syndrome
    Hassan Kamran, Hani M. Jneid, Waleed Tallat Kayani, Salim S. Virani, Glenn N. Levine, Vijay Nambi, Umair Khalid · 2021 · JAMA
83. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments
    Peter C. A. Kam, C. M. Nethery · 2003 · Anaesthesia
84. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study
    Sanjit S. Jolly, Janice M. Pogue, K. Haladyn, Ron J.G. Peters, Keith A.A. Fox, Álvaro Avezum, Bernard J. Gersh, H. J. Rupprecht, Salim Yusuf, Shamir R. Mehta · 2008 · European Heart Journal
85. Platelet Activation by Extracellular Matrix Proteins in Haemostasis and Thrombosis
    Steve P. Watson · 2009 · Current Pharmaceutical Design
86. Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
    Stephen D. Wiviott, Marcus D Flather, Michelle L. O’Donoghue, Shinya Goto, Desmond J. Fitzgerald, Fernando A. Cura, Philip E. Aylward, Victor Guetta, Dariusz Dudek, Charles F. Contant et al. · 2011 · Circulation
87. Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association
    François Schiele, Chris P Gale, Eric Bonnefoy‐Cudraz, Frédéric Capuano, Marc J. Claeys, Nicolas Danchin, Keith A.A. Fox, Kurt Huber, Zaza Iakobishvili, Maddalena Lettino et al. · 2016 · European Heart Journal Acute Cardiovascular Care
88. Usefulness of Complete Blood Count (CBC) to Assess Cardiovascular and Metabolic Diseases in Clinical Settings: A Comprehensive Literature Review
    In‐Ho Seo, Yong‐Jae Lee · 2022 · Biomedicines
89. Advanced Age, Antithrombotic Strategy, and Bleeding in Non–ST-Segment Elevation Acute Coronary Syndromes
    Renato D. Lópes, Karen P. Alexander, Steven V. Manoukian, Michel E. Bertrand, Frederick Feit, Harvey Douglas White, Charles V. Pollack, James W. Hoekstra, Bernard John Gersh, Gregg W. Stone et al. · 2009 · Journal of the American College of Cardiology
90. G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy
    Susan S. Smyth, Donna S. Woulfe, Jeffrey Ian Weitz, Christian Gachet, Pamela B. Conley, Shaun G. Goodman, Matthew T. Roe, Athan Kuliopulos, David J. Moliterno, Patricia A. French et al. · 2008 · Arteriosclerosis Thrombosis and Vascular Biology
91. Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activation
    Stefano Manarini, Giuseppe Dell’Elba, Nicola Martelli, Emanuela Napoleone, Angelomaria Di Santo, Pierre Savi, Roberto Lorenzet, Virgilio Evangelista · 2005 · Thrombosis and Haemostasis
92. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial
    Uwe Zeymer, Hans-Richard Arntz, Bernd Mark, Stephan Fichtlscherer, Gerald S. Werner, Ralph Schoeller, Ralf Zahn, Frank Diller, Harald Darius, Thorsten Dill et al. · 2011 · Clinical Research in Cardiology
93. Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy.
    T. Gremmel, M. Müller, S. Steiner, Daniela Seidinger, R. Koppensteiner, C. Kopp, S. Panzer · 2013 · Nephrology, Dialysis and Transplantation
94. The Efficacy and Safety of Perioperative Antiplatelet Therapy
    Jack Merritt, Deepak L. Bhatt · 2002 · Journal of Thrombosis and Thrombolysis
95. Bedside Evaluation of Thienopyridine Antiplatelet Therapy
    Matthew J. Price · 2009 · Circulation
96. The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
    Cian P. McCarthy, Philippe Gabríel Steg, Deepak L. Bhatt · 2017 · European Heart Journal
97. Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management
    Gregory Y.H. Lip, Anthony H Barnett, A W Bradbury, Francesco Paolo Cappuccio, Paramjit Singh Gill, E. A. Hughes, Chris Imray, Kate B Jolly, Kiran Patel · 2007 · Journal of Human Hypertension
98. Ticagrelor — Is There Need for a New Player in the Antiplatelet-Therapy Field?
    Albert Schömig · 2009 · New England Journal of Medicine
99. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack
    Stefan Karl James, Robert F. Storey, Nardev Singh Khurmi, Steen Husted, Mátyás Keltai, Kenneth W. Mahaffey, Juan Francisco Maya, João Morais, Renato D. Lópes, José Carlos Nicolau et al. · 2012 · Circulation
100. Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation
     Probal K. Roy, Laurent Bonello, Rebecca Torguson, Axel de Labriolle, Gilles Lemesle, Tina L. Pinto Slottow, Daniel Howard Steinberg, Kimberly Kaneshige, Zhenyi Xue, Lowell F. Satler et al. · 2008 · The American Journal of Cardiology